Tina Bhutani

Summary

Publications

  1. doi request reprint Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study
    Tina Bhutani
    Department of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:348-50. 2013
  2. doi request reprint A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
    Tina Bhutani
    Department of Dermatology, University of California, San Francisco, California, USA
    J Am Acad Dermatol 69:e79-88. 2013
  3. doi request reprint Efficacy of clobetasol spray: factors beyond patient compliance
    Tina Bhutani
    University of California, Department of Dermatology, San Francisco, San Francisco, CA, USA
    J Dermatolog Treat 23:11-5. 2012
  4. ncbi request reprint A review of the chemopreventative effects of oral retinoids for internal neoplasms
    Tina Bhutani
    Psoriasis and Skin Treatment Center, University of California San Francisco, CA 94118, USA
    J Drugs Dermatol 10:1292-8. 2011
  5. doi request reprint Common sources of skin care education: a cross-sectional study
    Tina Bhutani
    Department of Dermatology, University of California, San Diego, CA, USA
    Int J Dermatol 48:506-12. 2009
  6. ncbi request reprint Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis
    Tina Bhutani
    University of California San Francisco, Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Drugs Dermatol 10:831-4. 2011
  7. doi request reprint Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series
    Tina Bhutani
    University of California, San Francisco, Psoriasis and Skin Treatment Center, San Francisco, California 94118, USA
    J Dermatolog Treat 22:75-8. 2011
  8. pmc The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables
    Michael Abrouk
    School of Medicine, University of California Irvine, Irvine, CA, USA
    Dermatol Ther (Heidelb) 6:325-31. 2016
  9. pmc The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy
    Tian Hao Zhu
    University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Dermatol Ther (Heidelb) 6:333-9. 2016
  10. doi request reprint Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study
    Shilpa Gattu
    University of California Irvine Medical Center, Irvine, CA, USA
    J Dermatolog Treat 23:103-8. 2012

Collaborators

Detail Information

Publications23

  1. doi request reprint Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study
    Tina Bhutani
    Department of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:348-50. 2013
    ....
  2. doi request reprint A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
    Tina Bhutani
    Department of Dermatology, University of California, San Francisco, California, USA
    J Am Acad Dermatol 69:e79-88. 2013
    ..Psoriasis significantly impacts patients' quality of life...
  3. doi request reprint Efficacy of clobetasol spray: factors beyond patient compliance
    Tina Bhutani
    University of California, Department of Dermatology, San Francisco, San Francisco, CA, USA
    J Dermatolog Treat 23:11-5. 2012
    ..Basic concepts in topical drug delivery and how they apply to this spray vehicle may further explain the greater efficacy of clobetasol spray...
  4. ncbi request reprint A review of the chemopreventative effects of oral retinoids for internal neoplasms
    Tina Bhutani
    Psoriasis and Skin Treatment Center, University of California San Francisco, CA 94118, USA
    J Drugs Dermatol 10:1292-8. 2011
    ..J Drugs Dermatol. 2011;10(11):1292-1298...
  5. doi request reprint Common sources of skin care education: a cross-sectional study
    Tina Bhutani
    Department of Dermatology, University of California, San Diego, CA, USA
    Int J Dermatol 48:506-12. 2009
    ..The resources used by the public to locate health information are important...
  6. ncbi request reprint Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis
    Tina Bhutani
    University of California San Francisco, Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Drugs Dermatol 10:831-4. 2011
    ..This strategy provides a highly effective, reliable and safe treatment option with minimal local and systemic adverse risks...
  7. doi request reprint Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series
    Tina Bhutani
    University of California, San Francisco, Psoriasis and Skin Treatment Center, San Francisco, California 94118, USA
    J Dermatolog Treat 22:75-8. 2011
    ..Large phase III trials have elucidated the much higher efficacy of adalimumab over etanercept; however, no head-to-head comparison data exist for these two medications...
  8. pmc The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables
    Michael Abrouk
    School of Medicine, University of California Irvine, Irvine, CA, USA
    Dermatol Ther (Heidelb) 6:325-31. 2016
    ..However, for individuals who have never received this therapy, the process of performing a self-injection can be daunting. There is lack of patient educational material on how to perform and optimize this treatment...
  9. pmc The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy
    Tian Hao Zhu
    University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Dermatol Ther (Heidelb) 6:333-9. 2016
    ..Goeckerman therapy currently consists of exposure to ultraviolet B light and application of crude coal tar. The details of the procedure can be confusing and challenging to understand for the first-time patient or provider...
  10. doi request reprint Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study
    Shilpa Gattu
    University of California Irvine Medical Center, Irvine, CA, USA
    J Dermatolog Treat 23:103-8. 2012
    ..Alefacept is a remittive treatment for generalized psoriasis but is rarely used due to its erratic efficacy...
  11. ncbi request reprint Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review
    Mio Nakamura
    A Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
    J Dermatolog Treat . 2016
    ..There have been rare reports of eczema occurring as an adverse effect of anti-tumor necrosis factor-alpha (TNFα) therapy...
  12. pmc The Patient's Guide to Psoriasis Treatment. Part 1: UVB Phototherapy
    Rasnik K Singh
    University of California Los Angeles, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Dermatol Ther (Heidelb) 6:307-13. 2016
    ..Ultraviolet B (UVB) phototherapy is an effective treatment for psoriasis compared to other systemic treatments. Currently there is a lack of easily accessible online patient educational material regarding this form of treatment...
  13. doi request reprint Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review
    Tian Hao Zhu
    a University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    J Dermatolog Treat 27:406-13. 2016
    ..The aim of this review was to update the incidence of TNFi-induced demyelinating diseases...
  14. ncbi request reprint Obsessive-compulsive skin disorders: a novel classification based on degree of insight
    Tian Hao Zhu
    a University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    J Dermatolog Treat . 2016
    ..Understanding the level of insight is thus an important first step for clinicians who routinely interact with these patients...
  15. pmc How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center
    Faranak Kamangar
    Department of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA
    J Dermatolog Treat 24:13-24. 2013
    ..Patients with lower income levels had increased cut backs in personal expenses due to co-payments (p = 0.001). Among respondents, the mean annual out-of-pocket expense for a biologic was $557.12 per year, with a range of $0-7000...
  16. doi request reprint Instant barrier repair: A pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis
    Kelly K Park
    Department of Dermatology, University of California San Francisco, Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:119-21. 2013
    ..1% cream twice daily to another lesion. Results after 2-week no treatment follow-up showed hydrogel patch had notable efficacy, and comparable to TAC 0.1% cream. Larger studies are needed to validate these results...
  17. doi request reprint Oral vitamin D, still a viable treatment option for psoriasis
    Faranak Kamangar
    Department of Dermatology, University of California, Davis School of Medicine, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:261-7. 2013
    ..Oral vitamin D is inexpensive and easily available. It is still a viable option and should not be forgotten as a possible treatment for psoriasis...
  18. doi request reprint Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels
    Tina Bhutani
    Department of Dermatology, University of California at San Francisco, San Francisco, USA
    JAMA Dermatol 149:717-21. 2013
    ..It is important for practicing dermatologists to recognize patients who may be less likely to seek care for this multifaceted systemic disease as well as to be aware of reasons for not seeing physicians...
  19. pmc Recent advances in phototherapy for psoriasis
    Mio Nakamura
    Department of Dermatology, University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California, USA
    F1000Res 5:. 2016
    ..Therefore, though one of the oldest therapeutic modalities for psoriasis, phototherapy remains a mainstay treatment with promise for further advancement. ..
  20. doi request reprint The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury
    Tian Hao Zhu
    University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Am J Clin Dermatol 17:257-63. 2016
    ..In fact, neuropeptides such as nerve growth factor, substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide may be important contributors of psoriatic disease and potential targets for future therapies. ..
  21. ncbi request reprint Uremic pruritus treated successfully with the Goeckerman Program
    Mio Nakamura
    Department of Dermatology, University of California San Francisco
    Dermatol Online J 22:. 2016
    ..Although further studies are necessary, Goeckerman therapy may be a promising treatment option when 23 available for severe UP intractable to conventional therapies. ..
  22. doi request reprint Quality-of-life instruments: evaluation of the impact of psoriasis on patients
    Misha M Heller
    Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco Medical Center, 515 Spruce Street, San Francisco, CA 94118, USA
    Dermatol Clin 30:281-91, ix. 2012
    ..These QoL instruments can be especially helpful in identifying those patients who would most benefit from systemic or biologic therapy...
  23. ncbi request reprint Treatment of psoriasis and long-term maintenance using 308 nm excimer laser, clobetasol spray, and calcitriol ointment: a case series
    Jillian W Wong
    University of Utah School of Medicine, Salt Lake City, UT, USA
    J Drugs Dermatol 11:994-6. 2012
    ..Long-term near-clearance of psoriasis was sustained after 6 months and one-year follow up periods without further therapy...